Frazier Life Sciences Management’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.8M Buy
4,424,725
+3,469,210
+363% +$13.9M 0.71% 29
2025
Q1
$3.32M Hold
955,515
0.15% 45
2024
Q4
$6.29M Sell
955,515
-295,271
-24% -$1.94M 0.26% 44
2024
Q3
$11.3M Buy
+1,250,786
New +$11.3M 0.45% 36